Literature DB >> 10540191

Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n).

P J Späth1, A G Sjöholm, G N Fredrikson, G Misiano, R Scherz, U B Schaad, B Uhring-Lambert, G Hauptmann, J Westberg, M Uhlén, C Wadelius, L Truedsson.   

Abstract

Properdin deficiency was demonstrated in three generations of a large Swiss family. The concentration of circulating properdin in affected males was < 0.1 mg/l, indicating properdin deficiency type I. Two of the nine properdin-deficient males in the family had survived meningitis caused by Neisseria meningitidis serogroup B without sequel. Two point mutations were identified when the properdin gene in one of the properdin-deficient individuals was investigated by direct solid-phase sequencing of overlapping polymerase chain reaction (PCR) products. The critical mutation was found at base 2061 in exon 4, where the change of cytosine to thymine had generated the stop codon TGA. The other mutation was positioned at base 827 in intron 3. The stop codon in exon 4 was also demonstrated by standard dideoxy sequencing in three additional family members. The question was asked if genetic factors such as partial C4 deficiency and IgG allotypes could have influenced susceptibility to meningococcal disease in the family. No relationship was found between C4 phenotypes and infection. Interestingly, the two properdin-deficient males with meningitis differed from the other properdin-deficient persons in that they lacked the G2m(n) allotype, a marker known to be associated with poor antibody responses to T-independent antigens. This implies that the consequences of properdin deficiency might partly be determined by independent factors influencing the immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540191      PMCID: PMC1905431          DOI: 10.1046/j.1365-2249.1999.01056.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

Review 1.  Thymus-independent and thymus-dependent responses to polysaccharide antigens.

Authors:  K E Stein
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

Review 2.  The role of complement in inflammation and phagocytosis.

Authors:  M M Frank; L F Fries
Journal:  Immunol Today       Date:  1991-09

3.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  Fluorescent detection of microsatellite polymorphisms: properdin deficiency linked to PFC microsatellite.

Authors:  D Agardi; M Pigg; A G Sjöholm; L Truedsson; P J Späth; E J Kuijper; C C Tijssen; L Tranebjaerg; K H Gustavson; P J Ulfendahl
Journal:  Exp Clin Immunogenet       Date:  1995

5.  Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: complement activation pathway requirements in defense against Neisseria meningitidis.

Authors:  H Fredlund; A G Sjöholm; B Selander; E Holmström; P Olcén; D Danielsson
Journal:  Int Arch Allergy Immunol       Date:  1993       Impact factor: 2.749

6.  Serum IgG and IgG subclass contents in different Gm phenotypes.

Authors:  V A Oxelius
Journal:  Scand J Immunol       Date:  1993-02       Impact factor: 3.487

7.  Recurrent meningococcal septicaemia and properdin deficiency.

Authors:  N A Cunliffe; N Snowden; E M Dunbar; M R Haeney
Journal:  J Infect       Date:  1995-07       Impact factor: 6.072

8.  Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency.

Authors:  J Westberg; G N Fredrikson; L Truedsson; A G Sjöholm; M Uhlén
Journal:  Genomics       Date:  1995-09-01       Impact factor: 5.736

9.  Linkage analysis in properdin deficiency families: refined location in proximal Xp.

Authors:  C Wadelius; M Pigg; M Sundvall; A G Sjöholm; P Goonewardena; E J Kuijper; C C Tijssen; A Jansz; P J Späth; U B Schaad
Journal:  Clin Genet       Date:  1992-07       Impact factor: 4.438

10.  Hereditary properdin deficiency in three families of Tunisian Jews.

Authors:  M Schlesinger; U Mashal; J Levy; Z Fishelson
Journal:  Acta Paediatr       Date:  1993-09       Impact factor: 2.299

View more
  17 in total

Review 1.  Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors:  S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.

Authors:  Yuko Kimura; Lin Zhou; Takashi Miwa; Wen-Chao Song
Journal:  J Clin Invest       Date:  2010-10       Impact factor: 14.808

4.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  A novel mutation W388X underlying properdin deficiency in a Finnish family.

Authors:  M Helminen; S Seitsonen; H Jarva; S Meri; I E Järvelä
Journal:  Scand J Immunol       Date:  2012-04       Impact factor: 3.487

7.  Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors:  Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

8.  Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.

Authors:  Youssif Mohammed Ali; Azam Hayat; Bayad Mawlood Saeed; Kashif S Haleem; Saleh Alshamrani; Hany I Kenawy; Viviana P Ferreira; Gurpanna Saggu; Anna Buchberger; Peter J Lachmann; Robert B Sim; Dimitrios Goundis; Peter W Andrew; Nicholas J Lynch; Wilhelm J Schwaeble
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.

Authors:  Marieta M Ruseva; Katherine A Vernon; Allison M Lesher; Wilhelm J Schwaeble; Youssif M Ali; Marina Botto; Terence Cook; Wenchao Song; Cordula M Stover; Matthew Caleb Pickering
Journal:  J Am Soc Nephrol       Date:  2012-11-26       Impact factor: 14.978

10.  Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin.

Authors:  Aline Dupont; Fatima Mohamed; Nur'Ain Salehen; Sarah Glenn; Lorenza Francescut; Rozita Adib; Simon Byrne; Hannah Brewin; Irina Elliott; Luke Richards; Petya Dimitrova; Wilhelm Schwaeble; Nina Ivanovska; Aras Kadioglu; Lee R Machado; Peter W Andrew; Cordula Stover
Journal:  Med Microbiol Immunol       Date:  2014-04-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.